Work

In situ tuning proangiogenic factor-mediated immunotolerance synergizes the tumoricidal immunity via a hypoxia-triggerable liposomal bio-nanoreactor

Year: 2020

Type: article

Abstract: Our work provides an alternative strategy for exerting efficient tumoricidal immunity in the proangiogenic factor-upregulated subpopulation of CRC patients and may have a wide-ranging impact on cancer immune-anti-angiogenic complementary therapy in clinics.

Source: Theranostics

DOI: 10.7150/thno.50806

Authors: Chen Chen, Shengchang Zhang, Rui Zhang, Peng Sun, Chongdeng Shi, Mohnad Abdalla, Anning Li, Jiawen Xu, Wei Du, Jing Zhang, Ying Liu, Chunwei Tang, Zhenmei Yang, Xinyi Jiang

Institutions: Shandong University, Shandong University of Traditional Chinese Medicine, Qilu Hospital of Shandong University, Shandong Provincial Hospital, Shandong First Medical University

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,671

Funders: Shandong University, National Natural Science Foundation of China

Awards: G1091769501, G1870138000, G2633834330, G3912431744, G4900079689, G5393988389, G6867614938, G7916350479

OpenAlex ID: W3096847712

FWCI: 1.882

Cites: 36

Cited by: 30

Related to: 10